<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="TAB3" orientation="portrait" position="float">
 <label>Table 3</label>
 <caption>
  <title>Randomized control trials for emerging drugs</title>
  <p>NCT ID: National Clinical Trial Identifier; oSOC: optimized standard of care; NET: neutrophil extracellular trap</p>
 </caption>
 <table frame="hsides" rules="groups">
  <colgroup span="1">
   <col span="1"/>
   <col span="1"/>
   <col span="1"/>
   <col span="1"/>
   <col span="1"/>
   <col span="1"/>
   <col span="1"/>
  </colgroup>
  <tbody>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Intervention</td>
    <td rowspan="1" colspan="1">NCT ID</td>
    <td colspan="2" rowspan="1">No. of participants</td>
    <td colspan="2" rowspan="1">Duration</td>
    <td rowspan="1" colspan="1">Phase</td>
    <td rowspan="1" colspan="1">Sponsor</td>
   </tr>
   <tr>
    <td colspan="8" rowspan="1">Stem cells</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Biological: PLX-PAD; biological: placebo</td>
    <td colspan="2" rowspan="1">NCT04389450</td>
    <td rowspan="1" colspan="1">140</td>
    <td rowspan="1" colspan="1">June 2020–September 2021</td>
    <td colspan="2" rowspan="1">Phase 2</td>
    <td rowspan="1" colspan="1">Pluristem Ltd.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Biological: MultiStem; biological: placebo</td>
    <td colspan="2" rowspan="1">NCT04367077</td>
    <td rowspan="1" colspan="1">400</td>
    <td rowspan="1" colspan="1">April 2020–August 2022</td>
    <td colspan="2" rowspan="1">Phase 2, phase 3</td>
    <td rowspan="1" colspan="1">Athersys, Inc</td>
   </tr>
   <tr style="background-color:#ccc">
    <td colspan="8" rowspan="1">Targeting NETs</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: dornase alfa inhalation solution (Pulmozyme)</td>
    <td colspan="2" rowspan="1">NCT04359654</td>
    <td rowspan="1" colspan="1">50</td>
    <td rowspan="1" colspan="1">May 2020–November 2020</td>
    <td colspan="2" rowspan="1">Phase 2</td>
    <td rowspan="1" colspan="1">University College, London</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: anakinra 149 MG/ML prefilled syringe (Kineret)</td>
    <td colspan="2" rowspan="1">NCT04443881</td>
    <td rowspan="1" colspan="1">180</td>
    <td rowspan="1" colspan="1">May 2020–March 2021</td>
    <td colspan="2" rowspan="1">Phase 2, phase 3</td>
    <td rowspan="1" colspan="1">Fundacion Miguel Servet</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: anakinra plus oSOC; drug: oSOC</td>
    <td colspan="2" rowspan="1">NCT04364009</td>
    <td rowspan="1" colspan="1">240</td>
    <td rowspan="1" colspan="1">April 2020–September 2020</td>
    <td colspan="2" rowspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">University Hospital, Tours</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: anakinra</td>
    <td colspan="2" rowspan="1">NCT04341584</td>
    <td rowspan="1" colspan="1">240</td>
    <td rowspan="1" colspan="1">April 2020–December 2020</td>
    <td colspan="2" rowspan="1">Phase 2</td>
    <td rowspan="1" colspan="1">Assistance Publique - Hôpitaux de Paris</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: standard treatment; drug: oral administration of colchicine plus herbal phenolic monoterpene fractions</td>
    <td colspan="2" rowspan="1">NCT04392141</td>
    <td rowspan="1" colspan="1">200</td>
    <td rowspan="1" colspan="1">April 2020–October 2020</td>
    <td colspan="2" rowspan="1">Phase 1, phase 2</td>
    <td rowspan="1" colspan="1">Kermanshah University of Medical Sciences</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: colchicine 1 MG oral tablet</td>
    <td colspan="2" rowspan="1">NCT04375202</td>
    <td rowspan="1" colspan="1">308</td>
    <td rowspan="1" colspan="1">April 2020–October 2020</td>
    <td colspan="2" rowspan="1">Phase 2</td>
    <td rowspan="1" colspan="1">University Of Perugia</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: colchicine; other: local standard of care</td>
    <td colspan="2" rowspan="1">NCT04328480</td>
    <td rowspan="1" colspan="1">2500</td>
    <td rowspan="1" colspan="1">April 2020–August 2020</td>
    <td colspan="2" rowspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Estudios Clínicos Latino América</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: colchicine plus symptomatic treatment (paracetamol); drug: symptomatic treatment (paracetamol or best symptomatic treatment based on doctor recommendations)</td>
    <td colspan="2" rowspan="1">NCT04416334</td>
    <td rowspan="1" colspan="1">1028</td>
    <td rowspan="1" colspan="1">May 2020–December 2020</td>
    <td colspan="2" rowspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Instituto de Investigación Marqués de Valdecilla</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: colchicine</td>
    <td colspan="2" rowspan="1">NCT04322565</td>
    <td rowspan="1" colspan="1">310</td>
    <td rowspan="1" colspan="1">April 2020–July 2020</td>
    <td colspan="2" rowspan="1">Phase 2</td>
    <td rowspan="1" colspan="1">Azienda Ospedaliero-Universitaria di Parma</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: colchicine; drug: placebo oral tablet</td>
    <td colspan="2" rowspan="1">NCT04322682</td>
    <td rowspan="1" colspan="1">6000</td>
    <td rowspan="1" colspan="1">March 2020–September 2020</td>
    <td colspan="2" rowspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Montreal Heart Institute</td>
   </tr>
   <tr>
    <td colspan="8" rowspan="1">Darunavir</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: darunavir and cobicistat</td>
    <td colspan="2" rowspan="1">NCT04252274</td>
    <td rowspan="1" colspan="1">30</td>
    <td rowspan="1" colspan="1">January 2020–December 2020</td>
    <td colspan="2" rowspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Shanghai Public Health Clinical Center</td>
   </tr>
   <tr>
    <td colspan="8" rowspan="1">Favipiravir</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: favipiravir; other: placebo</td>
    <td colspan="2" rowspan="1">NCT04336904</td>
    <td rowspan="1" colspan="1">100</td>
    <td rowspan="1" colspan="1">March 2020–July 2020</td>
    <td colspan="2" rowspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Giuliano Rizzardini</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: favipiravir; drug: standard of care</td>
    <td colspan="2" rowspan="1">NCT04434248</td>
    <td rowspan="1" colspan="1">330</td>
    <td rowspan="1" colspan="1">April 2020–July 2020</td>
    <td colspan="2" rowspan="1">Phase 2, phase 3</td>
    <td rowspan="1" colspan="1">Chromis LLC</td>
   </tr>
   <tr style="background-color:#ccc">
    <td colspan="8" rowspan="1">Arbidol</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: carrimycin; drug: lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate; drug: basic treatment</td>
    <td colspan="2" rowspan="1">NCT04286503</td>
    <td rowspan="1" colspan="1">520</td>
    <td rowspan="1" colspan="1">February 2020–February 2021</td>
    <td colspan="2" rowspan="1">Phase 4</td>
    <td rowspan="1" colspan="1">Beijing YouAn Hospital</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: Arbidol; other: basic treatment</td>
    <td colspan="2" rowspan="1">NCT04260594</td>
    <td rowspan="1" colspan="1">380</td>
    <td rowspan="1" colspan="1">February 2020–December 2020</td>
    <td colspan="2" rowspan="1">Phase 4</td>
    <td rowspan="1" colspan="1">Jieming QU</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
